180
Participants
Start Date
February 15, 2021
Primary Completion Date
October 1, 2025
Study Completion Date
December 31, 2025
Aspirin 81 mg
Subjects in the interventional arm will receive a daily dose of aspirin 81 mg, starting at their baseline visit and to be taken up to their 6-month follow-up visit.
Placebo
Subjects in this group will receive a daily dose of a placebo pill, starting at their baseline visit and to be taken up to their 6-month follow-up visit.
RECRUITING
University of Chicago Hospital, Chicago
University of Chicago
OTHER